Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Protagen AG; Tepnel Pharma Services; and More

NEW YORK (GenomeWeb) — Diagnostic tools developer Protagen AG announced this week that it will join the RA-MAP Consortium, a collaboration of 10 universities and 10 companies working together to identify the key predictors of clinical response and remission in rheumatoid arthritis (RA) patients, and to identify those at high risk of developing the disease. Protagen will contribute its proprietary SeroTag diagnostic platform to search for RA biomarkers.

Hologic business unit Tepnel Pharma Services announced this week that it has been awarded ISO 17025:2005 accreditation for DNA extraction from whole blood using nucleon chemistry, and for DNA genotyping using InvaderPLUS, by the United Kingdom Accreditation Service.

Flagship Biosciences said this week that it has created a Clinical Trials and Regulatory Affairs Group in partnership with in vitro diagnostics developer DOCRO to develop image analysis-based companion diagnostics for the clinical market. The group will be led by Holger Lange, an expert in regulatory strategies for digital pathology platforms, the company said. He has previously successfully led five US Food and Drug Administration 510(k) clearances.

In Brief This Week is a selection of news items that may be of interest to our readers but had not previously appeared on the GenomeWeb site.